Hypertension Scientific Sessions 2024

The KCVD Council presented a plaque to Donald Seldin Lector Tianxin Yang, MD, PHD, FAHA at Hypertension 2024 in Chicago.

Key Dates

Hypertension 2025 Key Dates
Date Activity
Spring 2025 Registration Opens
September 4–7, 2025 Hypertension 2025 Scientific Sessions
Marriott Baltimore Waterfront

Why you should attend

Hypertension Scientific Sessions

Connect with cross-disciplinary researchers from around the world and engage with experts at the leading global medical meeting  on hypertension. Discover the latest in hypertension research and foster lasting relationships with researchers  and clinicians across multiple fields and at every stage of their careers.

This meeting features oral and poster presentations, followed by discussions with leading authorities in hypertension as it relates to cardiac and kidney disease, stroke, obesity and genetics. Specially designed sessions benefit trainees and early career investigators, covering topics from applying clinical science to practical advice for primary care providers.


Featured Speakers for 2024

David G. Harrison, MD, FAHA, FACC

David G. Harrison, MD, FAHA, FACC

Presentation Title: Immune Mechanisms of Hypertension
Session: 02. Keynote Lecture
When: Thursday, Sept. 5, 2024, 9:10 a.m. to 10:10 a.m.


David Harrison is the Betty and Jack Bailey Professor of Medicine and Director of the Division of Clinical Pharmacology at Vanderbilt University. He obtained his M.D. degree from the University of Oklahoma and received internal medicine and cardiology training at Duke University. He performed a research fellowship at the University of Iowa Cardiovascular Center from 1980 to 1982. In 1982, he joined the faculty at Iowa where he remained until 1990, when he moved to Emory University. While at Emory, he served as Director of the Cardiology Division from 2000 to 2009. In 2011, Dr. Harrison moved to his current position at Vanderbilt.

Dr. Harrison has received substantial recognition for his research contributions. He has received the Basic Science Distinguished Achievement Award from the Basic Science Council of the American Heart Association, the Novartis Award from the High Blood Pressure Council of the AHA for outstanding hypertension research in 2004. He was awarded the Carl J. Wiggers Award of the Cardiovascular Section of the American Physiological Society in 2010. In 2010 he also received the Distinguished Scientist Award from the American Heart Association. In 2012, he received the Irvine Page Distinguished Scientist Award from the American Society of Hypertension. He is the recipient of the 2018 Basic Science Prize from the American Heart Association.

Benjamin D. Humphries, MD, PhD

Benjamin D. Humphreys, MD, PhD

Presentation Title: Insights into Acute Kidney Injury and Transition to Chronic Kidney Disease Revealed by Multiomic and Spatial Technologies
Session: 01. Opening Remarks and Keynote Lecture
When: Thursday, Sept. 5, 2024, 8:00 a.m. to 9:00 a.m.



Dr. Benjamin Humphreys received his AB from Harvard college and his M.D. and Ph.D. degrees from Case Western Reserve University as part of the Medical Scientist Training Program. He trained in internal medicine at Massachusetts General Hospital and in nephrology at Brigham and Women’s Hospital where he subsequently joined the faculty. Dr. Humphreys is Chief of the Division of Nephrology and the Joseph Friedman Professor of Renal Diseases in Medicine at Washington University in St. Louis. He is past president of the American Society for Clinical Investigation, one of the nation’s oldest medical honor societies.

In 2021, he joined the Board of Scientific Counselors for the National Institute of Diabetes and Digestive and Kidney Diseases, a unit of the NIH. An internationally recognized investigator in kidney injury, fibrosis, organoids and regenerative medicine, current efforts in his laboratory focus on single cell multi-omics and spatial transcriptomics as approaches to understand and sub-phenotype human kidney disease.

Alexander Staruschenko, PhD, FAHA

Alexander Staruschenko, PhD, FAHA

Presentation Title: Kidney Metabolism and its Role in Hypertension
Session: 23. Keynote: Council on Kidney in Cardiovascular Disease Past Chair Lecture
When: Sunday, Sept. 8, 11:00 a.m. to 11:30 a.m.



Dr. Alexander (Sasha) Staruschenko is a Professor and Director of the Hypertension and Kidney Research Center at the University of South Florida. His research focuses on the mechanisms controlling ion channels and electrolyte homeostasis in blood pressure regulation and kidney diseases. Funded by the NIH, VA, AHA, and others, he has published over 180 peer-reviewed papers in top nephrology and hypertension journals.

Dr. Staruschenko has mentored numerous students, postdocs, and junior faculty, earning national recognition through over 100 invited talks and awards from the American Heart Association, American Physiological Society, and American Society of Nephrology. Dr. Staruschenko is an active member of several national societies and contributes significantly to their activities. He serves on the editorial boards of several journals, including his role as Deputy Editor of Am J Physiol: Renal Physiol. He has chaired the KCVD Council and served on the Leadership Committees for both the KCVD and Hypertension Councils. Additionally, he has been a chair, standing member, and ad hoc reviewer for numerous study sections, including those for the NIH, VA, DOD, ADA, AHA, and various international agencies.

 

Hypertension 2024 Executive Committee
Jane F. Reckelhoff, PhD, FAHA

Jane F. Reckelhoff, PhD, FAHA

Chair
Thu Le, MD

Thu Le, MD, FAHA

Vice Chair
Wanpen Vongpatanasin, MD, FAHA

Wanpen Vongpatanasin, MD, FAHA

Clinical Chair
Program Committee Members
  • Barbara Alexander, PhD
  • Christopher Banek, PhD
  • Mariane Bertagnolli, PhD
  • Vivek Bhalla, PhD
  • Heddwen Brooks, MSc, PhD
  • Daniele Carnevale, PhD
  • Yumei Feng, MD, PhD, FAHA
  • R. Ariel Gomez, MD, FAHA (Immediate Past Chair)
  • Giuseppe Lembo, MD, PhD
  • Maria Luisa Sequeira Lopez, MD
  • Cameron McCarthy, PhD, FAHA (Liaison, Trainee Advocacy Committee)
  • Dominek Mueller, PhD
  • Curt Sigmund, PhD, FAHA (ex-officio)
  • Johannes Stegbauer, MD
  • Stephanie Watts, PhD, FAHA
Clinical Practice/Clinical Science Program Subcommittee
Meena Madhur, MD, PhD, FACC, FAHA
Meena Madhur, MD, PhD, FACC, FAHA
Indiana University School of Medicine
Co-Chair
 
Eugene Yang Headshot
Eugene Yang, MD, FACC 
University of Washington School of Medicine
Co- Chair

Members

  • Nisha Bansal MD, MAS
  • Jan Basile, MD
  • Jennifer Brown, MD
  • Jordana Cohen, MD, MSCE
  • John Dodson, MD, MPH
  • Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA
  • Joseph Flynn, MD, MS
  • Lama Ghazi, MD, PhD
  • Karen A. Griffin, M., FAHA, FASN, FACP
  • Alan L. Hinderliter, MD
  • Luke Laffin, MD
  • James M. Luther, MD, MSCI
  • Raj Padwal, MD
  • Kristi Reynolds, PhD, MPH, FAHA, FACE
  • Brandi Wynne, PhD, FAHA
Primary Care Track Program Subcommittee
Valy Fontil, MD
Valy Fontil, MD
NYU Langone Health
Co-Chair
Stephen P. Juraschek, MD, PhD, FAHA
Stephen P. Juraschek, MD, PhD, FAHA, AHSCP-CHS
Harvard Medical School
Co-Chair

Members

  • Jan Basile, MD
  • Michael Bloch, MD
  • Shari Bolen, MD, MPH
  • Adam Bress, PharmD, MS
  • Alexander Chang, MD, MS
  • Jennifer Cluett, MD
  • Dave L. Dixon, PharmD, FACC, FAHA, FCCP, FNLA, BCACP, CDCES, CLS
  • Brent Egan, MD
  • Beverly B. Green, MD, MPH
  • Ian Kronish, MD, MPH
  • Anastasia Mihailidou, PhD
  • Joshua Samuels, MD, MPH
  • Anthony Viera, MD
  • Hilary K. Wall, MPH
  • Steven A Yarows, MD, FACP, FASH

Childcare

The American Heart Association is committed to supporting women and families in science and medicine, and will offer onsite childcare centers for all scientific conferences during conference and special activity hours.

Childcare is available for children between the ages of 6 months and 12 years.

A young smiles as she plays colored blocks with a little girl.

Looking for a new job opportunity? Check out our AHA Professional Member 2024 Featured Cardiovascular & Stroke Jobs Guide now!: View now to browse open positions from top healthcare employers!

AHA Policies and Guiding Values

The American Heart Association policies on conflict of interest, ethics and inclusiveness and our guiding values reflect the high standard of business conduct that has always been, and remains, a hallmark of our organization.

An AHA Scientific Sessions attendee walks past the American Heart Association logo on an electronic wall.

Questions?

Registration

Contact: [email protected]
Phone: 1-508-743-8517
Monday through Friday, 9am to 5pm ET


Exhibit at Hypertension(link opens in new window)

Conference & Media

Conference Contact: [email protected]
Phone: 1-888-242-2453 or 214-570-5935

Media Inquiries
American Heart Newsroom
Email: [email protected]
Phone: 214-706-1173

American Heart Association - We Heart our Members! Exclusive member discounts, education, resources, & events. Join or Renew